
Click to view full size
Barbados and its Nigerian partners, working with the African Export-Import Bank (Afreximbank), are advancing a pharmaceutical manufacturing project with an estimated investment cost of US$32 million, strengthening Africa-Caribbean industrial cooperation and regional health security.
The investment is intended to establish an intravenous fluids manufacturing facility in Barbados, with an initial annual capacity of 12 million units and scope for expansion.
Additional pharmaceutical products could follow, subject to technical, commercial and regulatory assessments.
The portable companion to gazettE. Get notifications, track read articles, and more. The latest news from Trinidad and Tobago, in one place.
Related stories
See articles related to "Barbados advances $32M pharmaceutical manufacturing project with Nigerian partners"